MiR-204-5p-targeted AP1S2 is necessary for papillary thyroid carcinoma

Yulu Gu,Xin Zhang,Yong Li,Jikang Shi,Heran Cui,Yaxuan Ren,Sainan Liu,Yichun Qiao,Yi Cheng,Yawen Liu
DOI: https://doi.org/10.1016/j.mce.2023.111993
IF: 4.369
2023-08-01
Molecular and Cellular Endocrinology
Abstract:MiR-204-5p, as a tumour suppressor, has been found in several cancers. However, whether miR-204-5p is involved in papillary thyroid carcinoma (PTC) has not yet been investigated. In this study, we identified miR-204-5p as a down-regulated miRNA in PTC tissues, unveiling that the levels of miR-204-5p in serum of patients with PTC were linked to PTC risk, and that the expression in patients concomitant with both PTC and benign lesions was much lower than that in patients only with PTC. Furthermore, we documented that miR-204-5p inhibited proliferation, migration, invasion, and cell cycle progression and triggered apoptosis of PTC cells via cell biology experiments. Finally, we identified that AP1S2 was a target of miR-204-5p using RNA-seq, iTRAQ, and bioinformatics prediction. Overall, miR-204-5p functions as a suppressor for PTC pathogenesis via the miR-204-5p/AP1S2 axis.
cell biology,endocrinology & metabolism
What problem does this paper attempt to address?